Graft-vs-Host Disease Management in the Modern Era: Expert Insights on Incorporating Recent Advances Into Care

Download these slides with expert recommendations on the management of patients with acute and chronic graft versus host disease (GVHD) after transplantation.
Corey Cutler, MD, MPH, FRCPC
Format: Microsoft PowerPoint (.ppt)
File Size: 3.62 MB
Released: April 13, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Incyte
Pharmacyclics Inc.

Related Content

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the expanding treatment options for hemophilia A & B

Stacy Croteau Headshot Stacy E. Croteau, MD, MMS
Program Director
Guy A. Young, MD
Program Director
Released: January 25, 2023

Data on JAK2 V617F molecular response from a study of ruxolitinib in patients with polycythemia vera or essential thrombocythemia, from ASH 2022 and reported by Clinical Care Options (CCO)

Released: December 19, 2022

New data from APPLY-PNH study of iptacopan in patients with paroxysmal nocturnal hemoglobinuria, presented at ASH 2022 and reported by Clinical Care Options (CCO)

Released: December 17, 2022

Results from phase II trial of second-in-class oral factor D inhibitor vemircopan in previously untreated patients with PNH, presented at ASH 2022 and reported by Clinical Care Options( CCO)

Released: December 16, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings